Femasys Inc. – NASDAQ:FEMY
Femasys stock price today
$0.695
-0.43
-38.5%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
Femasys stock price monthly change
-0.88%
month
Femasys stock price quarterly change
-0.88%
quarter
Femasys stock price yearly change
+18.95%
year
Femasys key metrics
Market Cap | 24.50M |
Enterprise value | N/A |
P/E | -1.14 |
EV/Sales | -1.45 |
EV/EBITDA | 0.17 |
Price/Sales | 5.40 |
Price/Book | 0.64 |
PEG ratio | 0.02 |
EPS | -0.85 |
Revenue | 1.04M |
EBITDA | -13.87M |
Income | -14.90M |
Revenue Q/Q | -7.77% |
Revenue Y/Y | -11.00% |
Profit margin | -923.74% |
Oper. margin | -936.4% |
Gross margin | 63.57% |
EBIT margin | -936.4% |
EBITDA margin | -1322.16% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeFemasys stock price history
Femasys stock forecast
Femasys financial statements
| Jun 2023 | 320.51K | -2.89M | -902.77% |
|---|---|---|---|
| Sep 2023 | 244.36K | -3.99M | -1635.66% |
| Dec 2023 | 213.11K | -4.41M | -2069.56% |
| Mar 2024 | 271.14K | -3.59M | -1327.55% |
| Sep 2025 | 4.46M | 0 | |
|---|---|---|---|
| Oct 2025 | 3.61M | -2.83M | -78.23% |
| Dec 2025 | 4.63M | 0 | |
| Dec 2025 | 4.03M | -1.95M | -48.53% |
Analysts Price target
Financials & Ratios estimates
| 2023-11-14 | -0.25 | -0.26 |
|---|---|---|
| 2024-03-28 | -0.19 | -0.19 |
| 2024-05-09 | -0.22 | -0.17 |
| Jun 2023 | 14313961 | 1.43M | 10.04% |
|---|---|---|---|
| Sep 2023 | 14853537 | 4.40M | 29.69% |
| Dec 2023 | 27755825 | 9.40M | 33.88% |
| Mar 2024 | 24370960 | 8.76M | 35.96% |
| Jun 2023 | -2.74M | -62.94K | 3.34M |
|---|---|---|---|
| Sep 2023 | -2.85M | -27.16K | 870.32K |
| Dec 2023 | -3.03M | -44.89K | 16.10M |
| Mar 2024 | -4.56M | -90.16K | 778.17K |
Femasys alternative data
| Aug 2023 | 34 |
|---|---|
| Sep 2023 | 34 |
| Oct 2023 | 34 |
| Nov 2023 | 34 |
| Dec 2023 | 34 |
| Jan 2024 | 34 |
| Feb 2024 | 34 |
| Mar 2024 | 34 |
| Apr 2024 | 34 |
| May 2024 | 32 |
| Jun 2024 | 32 |
| Jul 2024 | 32 |
Femasys other data
7.31%
-1.37%
of FEMY is owned by hedge funds
863.78K
-161.18K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2021 | 200500 | 0 |
-
What's the price of Femasys stock today?
One share of Femasys stock can currently be purchased for approximately $0.7.
-
When is Femasys's next earnings date?
Unfortunately, Femasys's (FEMY) next earnings date is currently unknown.
-
Does Femasys pay dividends?
No, Femasys does not pay dividends.
-
How much money does Femasys make?
Femasys has a market capitalization of 24.50M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 11.13% to 1.07M US dollars. Femasys made a loss 14.25M US dollars in net income (profit) last year or -$0.17 on an earnings per share basis.
-
What is Femasys's stock symbol?
Femasys Inc. is traded on the NASDAQ under the ticker symbol "FEMY".
-
What is Femasys's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of Femasys?
Shares of Femasys can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Femasys have?
As Jul 2024, Femasys employs 32 workers, which is 6% less then previous quarter.
-
When Femasys went public?
Femasys Inc. is publicly traded company for more then 4 years since IPO on 18 Jun 2021.
-
What is Femasys's official website?
The official website for Femasys is femasys.com.
-
Where are Femasys's headquarters?
Femasys is headquartered at 3950 Johns Creek Court, Suwanee, GA.
-
How can i contact Femasys?
Femasys's mailing address is 3950 Johns Creek Court, Suwanee, GA and company can be reached via phone at +7 705003910.
Femasys company profile:
Femasys Inc.
femasys.comExchange:
NASDAQ
Full time employees:
32
Industry:
Medical - Instruments & Supplies
Sector:
Healthcare
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
3950 Johns Creek Court
Suwanee, GA 30024
Suwanee, GA 30024
CIK: 0001339005
ISIN: US31447E1055
CUSIP: 31447E105
